Vzácná onemocnění 2

16 | www.solen.cz 4. Bednařík J, Voháňka S, Ehler E, Ambler Z, Piťha J, Vencovský J, Litzman J, Kořístek Z, Suchý M, Pátá M, Kožený P. Standard pro léčbu pacientů s autoimunitními nervosvalovými onemocněními intravenózním lidským imunoglobulinem a plazmaferézou. Ces Slov Neurol N 2010; 73: 579–586. 5. Buttmann M, Kaveri S, Hartung HP. Polyclonal immunoglobulin G for autoimmune demyelinating nervous system disorders. Trends Pharmac Sci 2013; 34(8): 445–457. 6. Costa RG, Bombelli F, Léger JM. Multifocal motor neuropathy. Presse Med 2013; 42: 217–224. 7. Dalakas MC. Pathophysiology of autoimmune polyneuropathies. Press Med 2013; 42: 181–192. 8. Dimachkie MM, Barohn JJ, Katz J. Multifocal motor neuropathy, multifocal acquired demyelinating sensory and motor neu- ropathy, and other chronic acquired demyelinating polyneuropathy variants. Neurol Clin 213; 31: 533–555. 9. Galassi G, Albertini G, Valzania F, Barbieri A. Cranial nerve involvement as presenting sign of multifocal motor neuropathy. Journal of Clinical Neuroscience 2012; 19: 1733–1735. 10. Galban-Horcajo F, Fitzpatrick AM, Hutton AJ, Dunn SM, Kalna G, Brennan KM, Rinaldi S, Yu RK, Goodyear CS, Willison HJ. An- tibodies to heteromeric glycolipide complexes in multifocal motor neuropathy. Eur J Neurol 2013; 20: 62–70. 11. Hartung HP, Lehmann HC, Kieseier BC, Hughes RAC. Novel treatment fot immune neuropathies on the horizon. J PNS 2011; 16: 75–83. 12. Joint Task Force of the EFNS and PNS. European federation of neurological societies/Peripheral nerve society guideline on management of multifocal motor neuropathy. Report of a Joint Task Force of the EFNS/PNS – first revision. Journal of the Pe- ripheral Nervous Systém 2010; 15: 295–301. 13. Leger JM, Salachas F. Diagnosis of motor neuropathy. Eur J Neurol 2001; 8: 201–208. 14. Markvardes LH, Harbo T, Sindrup SH, Christiansen I, Andersen H, Jakobsen J, The Danish CIDP and MMN Study Group. Eur J Neurol 2014; Jul 7. doi: 10.1111/ene.12513. 15. Muley SA, Parry GJ. Multifocal motor neuropathy. Journal of Clinical Neuroscience 2012; 19: 1201–1209. 16. Pestronk A, Cornblath DR, Ilyas AA, Baba H, Quarles RH, Griffin JW, Alderson K, Adams RN. A treatable multifocal motor neu- ropathy with antibodies to GM1 ganglioside. Ann Neurol 1988; 24: 73–78. 17. Pourmand R. Immune-mediated neuromuscular diseases. Basel: Karger, 2009. 18. Ramdas S, Prasad M, Spilane K, Kirkpatrick M. Acute motor neuropathy with pure distal involvement – A case report of mul- tifocal motor neuropathy. Eur J Ped Neurol 2013; 17: 415–418. 19. Ross MA. Electrodiagnosis of peripheral neuropathy. Neurol Clin 2012; 30: 529–549. 20. Roth G, Rohr J, Magistris MR, Oschner F. Motor neuropathy with proximal multifocal persistent block, fasciculations and myokymia. Evolution to tetraplegia. Eur Neurol 1986; 25: 416–423. 21. Uncini A. A common mechanism and a new categorization for anti-ganglioside antibody-mediated neuropathies. Exp Neurology 2012; 235: 513–516. 22. Uncini A, Susuki K, Yuki N. Nodo-paranodopathy: Beyond the demyelinating and axonal classification in anti-ganglioside antibody-mediated neuropathies. Clin Neurophys 2013; 124: 1928–1934. 23. Van den Bergh PYG, Rajabally YA. Chronic inflammatory demyelinating polyradiculoneuropathy. Press Med 2013;42:203–215. 24. Vlam L, van der Pol WL, Cats EA, Straver DC, Piepers S, Franssen H, van den Berg LH. Multifocal motor neuropathy: diagno- sis, pathogenesis and treatment strategies. Nat Rev Neurol 2011; 8: 48–58. 25. Van Shaik IN, Bouche P, Illa I, Léger JM, van den Bergh P, Cornblath DR, Evers EMA, Hadden RMD, Hughes RAC, Koski CL, No- bile-Orazio E, Pollard J, Sommer C, van Doorn PA: European federation of neurological societies/Peripheral nerve society gui- deline on management of multifocal motor neuropathy. Eur J Neurol 2006; 13: 802–802. doc. MUDr. Edvard Ehler, CSc. Neurologická klinika PKN, a.s. a FZS Univerzity Pardubice Kyjevská 44, 530 00 Pardubice edvard.ehler@nemocnice-pardubice.cz